- protein he is New hope from researchers Corona Erlangen
- Corona risk factors To be predicted How severe is the course of the disease Fill up
- Biomarker: What matters is Protein concentration
Some people who have contracted the Coronavirus hardly notice anything. Others become seriously ill and have to be hospitalized. About the Risk factors Even today – one year after the global outbreak of the Covid-19 pandemic – there is still no absolute clarity. Erlangen Researchers She now has references to one Biological marker Discover, The dependent Anticipate acute disease progression and possibly even enable treatment.
So far, one thing is certain: Older adults have a higher chance of contracting a serious illness from Covid-19. Other factors, such as smoking, increase the risk of serious illnesses. Obesity can also promote acute progression.
However, there is still no agreement on the mechanisms that increase the risk of developing severe corona diseases. And time and time again, people become seriously ill and don’t actually belong to any at-risk group.
Corona disease cycle: Protein concentration should help predict
Two doctors from Erlangen – Dr. George Weber, Deputy Director of the Clinic and Chief Physician of the Surgical Clinic at the University Hospital Erlangen, Dr. Alan Bennard, employee of the surgical clinic – now there is hope for better identification of severe diseases. Treatment is even possible.
With other researchers from the working group.Cellular immunity in cases of inflammation and cancer“The University of Klinik Erlangen is important Verhindicator To find out if a viral infection is mild or severe: Immunbottnstof Interleukin 3. The results of the study appear in the journal Nature Communications“.
Interleukin-3 is a proteinWhich Stimulates the natural immune defense in humans. It stimulates blood formation and is therefore used, for example, after bone marrow transplants, in general anemia or after chemotherapy to enhance blood formation.
Immunotherapy: A new treatment method can protect the lungs from infection with the Coronavirus
Weber and Banard now showed in a study that A. Low levels of interleukin 3 In blood plasma often with a Severe course of Covid-19 disease It goes hand in hand. Interleukin-3 plays a major role in regulating the body’s immune response. At the site of inflammation – for example, SARS-Cov-2 pneumonia – it stimulates cells there to produce the protein CXCL12.